Buscar en
Annals of Hepatology
Toda la web
Inicio Annals of Hepatology Most Often Read Most Often Read
Journal Information

Most Often Read

5414
COVID-19 and the liver: What do we know after six months of the pandemic?
Nora A. Fierro
Ann Hepatol. 2020;19:590-1
5414
Open access
Open Article
2955
The relative expression of hepatocellular and cholestatic liver enzymes in adult patients with liver disease
Daniel Iluz-Freundlich, Manna Zhang, Julia Uhanova, Gerald Y. Minuk
Ann Hepatol. 2020;19:204-8
2955
Open access
2895
The liver in times of COVID-19: What hepatologists should know
Ezequiel Ridruejo, Alejandro Soza
Ann Hepatol. 2020;19:353-8
2895
Open access
Open Article
2577
Bacterial infections in cirrhosis: Current treatment
Godolfino Miranda-Zazueta, Luis A. Ponce de León-Garduño, Jonathan Aguirre-Valadez, Aldo Torre-Delgadillo
Ann Hepatol. 2020;19:238-44
2577
Open access
1926
Mechanisms of kidney dysfunction in the cirrhotic patient: Non-hepatorenal acute-on-chronic kidney damage considerations
María-Jimena Muciño-Bermejo
Ann Hepatol. 2020;19:145-52
1926
Open access
1677
Vanishing bile duct syndrome related to DILI and Hodgkin lymphoma overlap: A rare and severe case
Raquel D. Greca, Marlone Cunha-Silva, Larissa B.E. Costa, Júlia G.F. Costa, Daniel F.C. Mazo, Tiago Sevá-Pereira, Marlla M.C. Nascimento, Isadora E. Pereira, Flávia C. Oliveira, Guilherme A.S. Faria, Fernando L.P. Neto, Jazon R.S. Almeida
Ann Hepatol. 2020;19:107-12
1677
Open access
1503
Ocular manifestations of liver disease in children: Clinical aspects and implications
Durga Prasad, Arpita Bhriguvanshi
Ann Hepatol. 2020;19:608-13
1503
Open access
1287
Chronic kidney disease in patients with non-alcoholic fatty liver disease: What the Hepatologist should know?
Stefania Kiapidou, Christina Liava, Maria Kalogirou, Evangelos Akriviadis, Emmanouil Sinakos
Ann Hepatol. 2020;19:134-44
1287
Open access
1203
Osteopontin – A potential biomarker of advanced liver disease
Radan Bruha, Libor Vitek, Vaclav Smid
Ann Hepatol. 2020;19:344-52
1203
Open access
1199
ABCB4 disease: Many faces of one gene deficiency
Eva Sticova, Milan Jirsa
Ann Hepatol. 2020;19:126-33
1199
Open access
1175
Metformin in the prevention of hepatocellular carcinoma in diabetic patients: A systematic review
Victor Cunha, Helma Pinchemel Cotrim, Raquel Rocha, Kellyane Carvalho, Liliane Lins-Kusterer
Ann Hepatol. 2020;19:232-7
1175
Open access
1000
Looking into a new era for the approach of metabolic (dysfunction) associated fatty liver disease
Alejandro Valencia-Rodríguez, Alfonso Vera-Barajas, Norberto C. Chávez-Tapia, Misael Uribe, Nahum Méndez-Sánchez
Ann Hepatol. 2020;19:227-9
1000
Open access
951
Multiple therapeutic targets in rare cholestatic liver diseases: Time to redefine treatment strategies
Alessio Gerussi, Daphne D’Amato, Laura Cristoferi, Sarah Elizabeth O’Donnell, Marco Carbone, Pietro Invernizzi
Ann Hepatol. 2020;19:5-16
951
Open access
924
Meta-analysis: The efficacy of metformin and other anti-hyperglycemic agents in prolonging the survival of hepatocellular carcinoma patients with type 2 diabetes
Jian Zhou, Yang Ke, Xuefen Lei, Tiangen Wu, Yuehua Li, Tianhao Bao, Haoran Tang, Cheng Zhang, Xuesong Wu, Ge Wang, Jinze Li, Heng Zhang, Fan Ni, Zhengchen Ye, Lin Wang
Ann Hepatol. 2020;19:320-8
924
Open access
906
Role of zinc supplementation in the management of chronic liver diseases: A systematic review and meta-analysis
Daniela C. Diglio, Sabrina A. Fernandes, Jessica Stein, André Azeredo-da-Silva, Angelo A. de Mattos, Cristiane V. Tovo
Ann Hepatol. 2020;19:190-6
906
Open access
867
Elevation of hepatic autophagy and antioxidative capacity by endurance exercise is associated with suppression of apoptosis in mice
Insu Kwon, Wankeun Song, Yongchul Jang, Myung D. Choi, Debra M. Vinci, Youngil Lee
Ann Hepatol. 2020;19:69-78
867
Open access
866
Association between sarcopenia and hepatic encephalopathy: A systematic review and meta-analysis
Karn Wijarnpreecha, Monia Werlang, Panadeekarn Panjawatanan, Paul T. Kroner, Wisit Cheungpasitporn, Frank J. Lukens, Surakit Pungpapong, Patompong Ungprasert
Ann Hepatol. 2020;19:245-50
866
Open access
856
A systematic review and meta-analysis of the COVID-19 associated liver injury
Yu Jun Wong, Malcolm Tan, Qishi Zheng, James Weiquan Li, Rahul Kumar, Kwong Ming Fock, Eng Kiong Teo, Tiing Leong Ang
Ann Hepatol. 2020;19:627-34
856
Open access
Open Article
835
Epidemiology and pathophysiology of the association between NAFLD and metabolically healthy or metabolically unhealthy obesity
Amedeo Lonardo, Alessandro Mantovani, Simonetta Lugari, Giovanni Targher
Ann Hepatol. 2020;19:359-66
835
Open access
810
Prevalence of liver fibrosis in an unselected general population with high prevalence of obesity and diabetes mellitus. Time for screening?
Diego García-Compeán, Jesús Zacarías Villarreal-Pérez, Manuel Enrique de la O. Cavazos, Fernando Javier Lavalle-Gonzalez, Omar David Borjas-Almaguer, Angel Noé Del Cueto-Aguilera, José Alberto González-González, Consuelo Treviño-Garza, Lourdes Huerta-Pérez, Héctor Jesús Maldonado-Garza
Ann Hepatol. 2020;19:258-64
810
Open access
es en pt

¿Es usted profesional sanitario apto para prescribir o dispensar medicamentos?

Are you a health professional able to prescribe or dispense drugs?

Você é um profissional de saúde habilitado a prescrever ou dispensar medicamentos